georgeclerk
Pfizer (NYSE:PFE) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform.
Under the deal, Alloy will receive an upfront payment from Pfizer (NYSE:PFE) and will be eligible for certain milestone payments,